| abstract |
Inhibitors of the CYP11B, CYP17 and/or CYP21 enzymes of formula Z, IX, X, XI, XII, XIII, XIV, XV, XVI or XVII are provided herein. Also described herein are pharmaceutical compositions comprising at least one of the compounds described herein, and the use of a compound or pharmaceutical composition described herein for the treatment of androgen-dependent diseases, disorders, and conditions. □ |